Granata Bio News and Resources

Granata Bio Corporation, a biopharma company addressing the global infertility medication market valued at $3.6 billion, has successfully closed a $15 million Series A+ funding round. This round was exclusively backed by existing investors, including Gedeon Richter, CooperSurgical, Amboy Street